CI
NTUS

Cambiar Investors’s Natus Medical Inc NTUS Stock Holding History

Cambiar Investors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-138,270
Closed -$4.71M – 177
2018
Q4 		$4.71M Sell
138,270
-9,973
-7% -$324K 0.11% 71
2018
Q3 		$5.29M Sell
148,243
-5,895
-4% -$208K 0.1% 80
2018
Q2 		$5.32M Sell
154,138
-33,013
-18% -$1.16M 0.09% 88
2018
Q1 		$6.3M Sell
187,151
-47,666
-20% -$1.51M 0.1% 80
2017
Q4 		$8.97M Buy
+234,817
New +$9.37M 0.14% 93

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cambiar Investors's NTUS Position: Q1 2019 in Review

Cambiar Investors sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 138,270 shares — an estimated $4.71M sold.

Cambiar Investors first reported a position in NTUS in Q4 2017 and held it in 5 quarters. The position peaked at $8.97M in Q4 2017. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • Cambiar Investors reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
  • Cambiar Investors sold 138,270 Natus Medical Inc shares in Q1 2019, an estimated $4.71M.
  • Cambiar Investors first reported a position in Natus Medical Inc in Q4 2017 and held it in 5 quarters.
  • Cambiar Investors's Natus Medical Inc position peaked at $8.97M in Q4 2017.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Cambiar Investors's 13F filing for Q1 2019, filed 8 May 2019.